Rare hemorrhagic disorder due to a constitutional thrombocytopenia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:275729
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Rare hemorrhagic disorder due to a constitutional thrombocytopenia is a broad grouping category (Orphanet code 275729) that encompasses a collection of inherited bleeding disorders characterized by a persistently reduced platelet count (thrombocytopenia) that is present from birth or early life due to an underlying genetic cause. Unlike acquired thrombocytopenias, which result from immune destruction, infections, or medications, constitutional (or inherited) thrombocytopenias arise from germline mutations affecting platelet production, maturation, or survival. These conditions affect the hematologic system primarily, leading to a variable bleeding tendency. Patients with these disorders may experience easy bruising (ecchymoses), prolonged bleeding from cuts or surgical procedures, petechiae (small red or purple spots on the skin), mucosal bleeding such as nosebleeds (epistaxis) and gum bleeding, heavy menstrual periods (menorrhagia) in women, and in severe cases, gastrointestinal or intracranial hemorrhage. The severity of bleeding symptoms varies widely depending on the specific underlying genetic defect and the degree of thrombocytopenia. Some patients may be relatively asymptomatic and discovered incidentally, while others may have clinically significant hemorrhagic episodes. Because this category encompasses multiple distinct genetic entities, the inheritance pattern, age of onset, and specific management vary by the individual condition. Treatment is generally supportive and may include platelet transfusions for severe bleeding episodes or prior to surgical procedures, antifibrinolytic agents such as tranexamic acid, and desmopressin (DDAVP) in select cases. Thrombopoietin receptor agonists have been explored in some subtypes. Hematopoietic stem cell transplantation may be considered in severe cases. Accurate genetic diagnosis is important to guide prognosis, management, and genetic counseling for affected families.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Rare hemorrhagic disorder due to a constitutional thrombocytopenia.

View clinical trials →

No actively recruiting trials found for Rare hemorrhagic disorder due to a constitutional thrombocytopenia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Rare hemorrhagic disorder due to a constitutional thrombocytopenia community →

No specialists are currently listed for Rare hemorrhagic disorder due to a constitutional thrombocytopenia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rare hemorrhagic disorder due to a constitutional thrombocytopenia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Rare hemorrhagic disorder due to a constitutional thrombocytopeniaForum →

No community posts yet. Be the first to share your experience with Rare hemorrhagic disorder due to a constitutional thrombocytopenia.

Start the conversation →

Latest news about Rare hemorrhagic disorder due to a constitutional thrombocytopenia

No recent news articles for Rare hemorrhagic disorder due to a constitutional thrombocytopenia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Rare hemorrhagic disorder due to a constitutional thrombocytopenia

What is Rare hemorrhagic disorder due to a constitutional thrombocytopenia?

Rare hemorrhagic disorder due to a constitutional thrombocytopenia is a broad grouping category (Orphanet code 275729) that encompasses a collection of inherited bleeding disorders characterized by a persistently reduced platelet count (thrombocytopenia) that is present from birth or early life due to an underlying genetic cause. Unlike acquired thrombocytopenias, which result from immune destruction, infections, or medications, constitutional (or inherited) thrombocytopenias arise from germline mutations affecting platelet production, maturation, or survival. These conditions affect the hemat